These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1764022

  • 1. Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.
    Bouscarel B, Fromm H, Ceryak S, Cassidy MM.
    Biochem J; 1991 Dec 15; 280 ( Pt 3)(Pt 3):589-98. PubMed ID: 1764022
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding.
    Bouscarel B, Ceryak S, Robins SJ, Fromm H.
    Lipids; 1995 Jul 15; 30(7):607-17. PubMed ID: 7564915
    [Abstract] [Full Text] [Related]

  • 3. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Bouscarel B, Ceryak S, Fromm H.
    Biochim Biophys Acta; 1996 Jun 11; 1301(3):230-6. PubMed ID: 8664333
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes.
    Bouscarel B, Fromm H, Nussbaum R.
    Am J Physiol; 1993 Feb 11; 264(2 Pt 1):G243-51. PubMed ID: 8447407
    [Abstract] [Full Text] [Related]

  • 5. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
    Ceryak S, Bouscarel B, Malavolti M, Robins SJ, Caslow KL, Fromm H.
    Atherosclerosis; 2000 Nov 11; 153(1):59-67. PubMed ID: 11058700
    [Abstract] [Full Text] [Related]

  • 6. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R.
    Hepatology; 1995 Jul 11; 22(1):82-7. PubMed ID: 7601437
    [Abstract] [Full Text] [Related]

  • 7. Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver.
    Spady DK, Stange EF, Bilhartz LE, Dietschy JM.
    Proc Natl Acad Sci U S A; 1986 Mar 11; 83(6):1916-20. PubMed ID: 3456612
    [Abstract] [Full Text] [Related]

  • 8. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
    Kubaska WM, Gurley EC, Hylemon PB, Heuman DM, Mosbach EH, Vlahcevic ZR.
    Biochim Biophys Acta; 1987 Aug 15; 920(3):195-204. PubMed ID: 3607077
    [Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC.
    Bouscarel B, Gettys TW, Fromm H, Dubner H.
    Am J Physiol; 1995 Feb 15; 268(2 Pt 1):G300-10. PubMed ID: 7864127
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T, Di Sario A, Baiocchi L, Jezequel AM.
    Hepatology; 1997 Jul 15; 26(1):9-21. PubMed ID: 9214446
    [Abstract] [Full Text] [Related]

  • 11. Modulation of low density lipoprotein receptor activity by bile acids: differential effects of chenodeoxycholic and ursodeoxycholic acids in the hamster.
    Malavolti M, Fromm H, Ceryak S, Roberts IM.
    J Lipid Res; 1987 Nov 15; 28(11):1281-95. PubMed ID: 2828498
    [Abstract] [Full Text] [Related]

  • 12. Comparative binding of bile acids to serum lipoproteins and albumin.
    Ceryak S, Bouscarel B, Fromm H.
    J Lipid Res; 1993 Oct 15; 34(10):1661-74. PubMed ID: 8245717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
    Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thörne A, Nowak G, Ericzon BG, Björkhem I, Einarsson C.
    Hepatology; 2003 Oct 15; 38(4):930-8. PubMed ID: 14512880
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, Panella C.
    Hepatology; 1996 May 15; 23(5):1159-66. PubMed ID: 8621149
    [Abstract] [Full Text] [Related]

  • 19. Effect of ursodeoxycholic acid administration on bile acid composition in hamster bile.
    Matejka M, Vescina C, Carducci CN, Alayón A, Dios A, Scarlatto E, Mamianetti A.
    Pharmacol Res; 1990 May 15; 22(3):297-305. PubMed ID: 2367280
    [Abstract] [Full Text] [Related]

  • 20. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G, Kloeters-Plachky P, Sauer P, Stiehl A.
    Eur J Clin Invest; 2002 Aug 15; 32(8):575-80. PubMed ID: 12190957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.